Skip to content

APSYZ

Active Private limited companyfounded 2024active for 2 yearsDrève des Arches 12, 5340 GesvesKBO/BCE: BE 1007.357.470

Overview

Lifetime

2 annual accounts with figures on one time axis
peak €71,308 (2025)
€71,308▲ 28.3%
peak €40,493 (2025)
€40,493▲ 49.4%
peak €70,588 (2025)
€70,588▲ 135%
€1,246▲ 82.3%
Board2 names since 2024
Documentsfilings and deeds
30-07-20261 day before the deadline
2025abbreviated format
Turnover from €55,560 to €71,308Gross margin from €37,005 to €55,172Result from €27,095 to €40,493Equity from €30,095 to €70,588Debts from €683 to €1,246Cash from €30,779 to €60,095

Key points

from the 2025 annual accounts

Investments

€9,196 49.3 × depreciation

Green is investment, beige is depreciation.

Board

1 left

A director left. Latest change 02-01-2026 · 1 in office.

Position in the sector

98.3%

Higher solvency than 95% of companies in human health. Sector median 59.2% · 3,053 companies.

Checked score

98
Excellent
Financially stronger than 87% of micro companies in human health (NACE 86)
Probability in this band: under 0.55%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

The dashed line is the sector median: < 0.1% across 24,185 companies (NACE 86, micro).

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Last 24 months 04-2025: 0.3% 05-2025: 0.3%● unchanged vs 04-2025 06-2025: 0.3%● unchanged vs 05-2025 07-2025: 0.3%● unchanged vs 06-2025 08-2025: 0.3%● unchanged vs 07-2025 09-2025: 0.3%● unchanged vs 08-2025highest value 10-2025: < 0.1%▼ -0.3 percentage points vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026lowest value 11-2026: < 0.1%● unchanged vs 10-2026lowest value

Financial strength
Strong

100=equity 98.3% of total assets
100=short-term debt 1.5% · cash 83.7%
100=return on assets 56.4%

Score breakdown

raises risk
Founded in 2024
lowers risk
Sector: Human health activities (NACE 86)
Liquidity: current ratio 58.35, cash €60,095
Equity €70,588 (98.3% of total assets)
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 82% of them on solvency, 95% on liquidity, 80% on profitability and 89% on growth.

The bankruptcy probability was computed on 09-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

The probability rests on the annual accounts with balance sheet date 31-12-2025.

Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Comparable companies, two years later

In July 2024, 39,278 companies had the same profile as APSYZ has now. Each dot stands for 99 companies, two years later.

95.8%
were still trading
2.3%
stopped another way
1.8%
went bankrupt
  • Micro
  • 2 to 5 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more

Another 0.1% stopped without a precise date, possibly only after those two years.

The bankruptcy probability of APSYZ itself is lower: < 0.1% within 12 months. It rests on far more data about APSYZ than the profile alone.

Test of the method

The method was tested on the 497,447 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 39,278 companies, not a prediction for APSYZ. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit of up to €6,000 on 30-day terms, only on tighter conditions: young company (under 3 years) without a track record

Liquidity is ample, with a current ratio of 58.35 (45.04 in 2024), above the usual 1.5. Short-term debt is 1.5% and cash 83.7% of total assets. 1.7% of the assets are financed with debt and provisions.

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskraises riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Liquidity: current ratio 58.35, cash €60,095
NBB · annual accounts
lowers risk · Equity €70,588 (98.3% of total assets)
NBB · annual accounts
raises risk · Founded in 2024
Companies of this age fail more often than older ones. How much that weighs depends on the rest of the company's profile.
KBO
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 30-07-2026, 1 day ahead of the deadline.
NBB · 2 filings
Deviation from the deadline
2025
1 day early
2024
28 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 2 accounts on average 14 days after the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Where today falls in the filing period
10-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since incorporation in 2024.
KBO publications

Board and ownership

  • LEROY Fabian Michel Laurent 50 sharesdeed of 22-03-2024
  • SZEDLESKI Christelle Marie Ghislaine 50 sharesdeed of 22-03-2024
Board & ownership

Recent changes

Resignation: Fabian Leroy (director) General meeting of 02-01-2026 · Gazette deed
Registered in the Peppol Directory Reachable for e-invoices through 0208:1007357470
Incorporation Founding capital of €3,000, 100 shares · Founders: LEROY Fabian Michel Laurent and SZEDLESKI Christelle Marie Ghislaine · Appointments: SZEDLESKI Christelle Marie Ghislaine (director) and LEROY Fabian Michel Laurent (director) · published on 22-03-2024 · Gazette deed
First establishment Drève des Arches 12, Gesves
All 6 events

Comparable companies

same main activity, similar in size and age
Company
APSYZ Gesves €71,834 €55,172 98.3% -
Curioza Tessenderlo-Ham €74,814 €48,189 75.9% -
Op Dreef Essen €85,344 €49,611 95.2% -
SALEV Uccle €87,038 €53,434 85.5% -
PSYCHO SEXO Sombreffe €95,843 €51,825 61.3% -
ARTEMISIA SENAY Gembloux €58,690 €51,537 76.4% -
Heartlink Psychology Leuven €72,854 €58,472 56.8% -

These companies have the same main activity as APSYZ: psychology services (NACE 86931). They are comparable in size and age: total assets between €58,700 and €95,800, founded in 2024.

Official details

Source: KBO
Status
Active since 20-03-2024Normal situation
Activity
Psychology servicesNACE 86931and 3 others
Establishment unit
2.358.898.2605340 Gesves, since 20-03-2024
Financial year end
31 December
Peppol
Reachable since 04-12-2025
Company details

Annual accounts 2025

€71,308▲ 28.3%
€40,493▲ 49.4%
€70,588▲ 135%
€71,834▲ 133%
Filing
Filed on 30-07-2026, 1 day before the end of the filing period
Financials

Insights on APSYZ

APSYZ has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €70,588 and a net result of €40,493.

Its solvency ranks better than 95% of 3,053 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Sources: KBO register, filings at the National Bank, Belgian Official Gazette.

Financials

Annual accounts 2025

abbreviated format, filed on 30-07-2026, 1 day before the deadline
€71,308
▲ 28.3%
€54,586
▲ 49.1%
€54,772
€40,679
98.3%
▲ 0.5 percentage points
58.35
▲ 13.31

Money flows

of every €100 of turnover, €56.79 remains as profit in 2025

Balance sheet

balance sheet total €71,834 on 31-12-2025
What the company ownsHow it is paid for

in euro

in euro

Position in the sector

98.3%

Higher than 95% of 3,053 companies in 2025.

58.35

Higher than 95% of 2,997 companies in 2025.

56.4%

Higher than 93% of 3,009 companies in 2025.

APSYZ Middle half of the sector 80% of the sector Abbreviated accounts in human health (NACE 86)

Net result: middle half · Equity: bottom quarter · Balance sheet total: bottom quarter · Working capital: middle half

Filed annual accounts

as filed with the National Bank, click a year to choose it
Line Trend20252024
Balance sheet: assets
20/58 71,83430,779
21/28 9,010-
22/27 9,010-
22 9,010-
29/58 62,82430,779
40/41 2,7230
40 -0
41 2,7230
54/58 60,09530,779
490/1 6-
Balance sheet: equity and liabilities
10/49 71,83430,779
10/15 70,58830,095
10/11 3,0003,000
14 67,58827,095
17/49 1,246683
42/48 1,077683
44 1240
440/4 1240
45 683683
450/3 683683
47/48 269-
492/3 169-
Income statement
70 71,30855,560
9900 55,17237,005
60/61 16,13618,555
630 186-
640/8 400387
9901 54,58636,618
75/76B -31
75 -31
65/66B 6657
65 6657
9903 54,52036,591
67/77 14,0279,496
9904 40,49327,095
9905 40,49327,095
Appropriation of the result
9906 67,58827,095
14P 27,095-
Document PDFPDF

The notes to these accounts have 5 items, including the statement of assets and debts, the cost breakdown and rights and commitments. You find them in the accounts filed with the NBB.

Source: Annual accounts 2025 at the NBB, filed on 30-07-2026.

Download as CSV

Filings

each dot is a set of accounts, on the day it reached the National Bank
Financial year Type Filed Reference Document
31-12-2025 abbreviated format 30-07-2026 2026-00380545 PDF
31-12-2024 full format 28-08-2025 2025-00464816 PDF

Key figures and ratios

per financial year, computed from the annual accounts
Line Trend20252024
54,772-
40,679-
9,196-
29,317-
61,74730,095
76.5%65.9%
98.3%97.8%
58.3545.04
0.020.02
57.4%90.0%
56.4%88.0%
over 100-
14 days0 days
3 days0 days

A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.

Investments

fixed assets acquired
Item20252024
Tangible fixed assets€9,196-
€186-

Source: notes to the 2024 to 2025 annual accounts (statement of fixed assets)

Insights on APSYZ

The operating result for 2025 is 49% higher than in 2024.

Debt's share of the balance-sheet total falls from 2.2% to 1.7%. Equity and debt are higher.

Board & ownership

Board

1 director, no change since January 2026
Director (not named in the articles)
appointed by deed of 22-03-2024 term without a fixed end
listed in the 2025 annual accounts, filed on 30-07-2026
Signing authorityThe articles say who may bind the company, for example by signing a contract.
Each director alone
deed of 22-03-2024

Office holders in the KBO →

Mandates through the years

2 names, the dashed line is today
SZEDLESKI Christelle Marie Ghislaine
Director (not named in the articles)
LEROY Fabian Michel Laurent
Director (not named in the articles)
BoardEarlier
Mandates as a list
  • SZEDLESKI Christelle Marie Ghislaine
    • Director (not named in the articles), appointed by deed of 22-03-2024, still in office
  • LEROY Fabian Michel Laurent
    • Director (not named in the articles), appointed by deed of 22-03-2024, until 02-01-2026

See the board, name and registered office on a given date →

Control

This company
APSYZ
Equity €70,588
Profit €40,493 in 2025

Capital

Contribution
€3,000
Shares
100
Contribution per share
€30
Equity per share
€706 in 2025
Source
deed of 22-03-2024

Articles of association

deed of 22-03-2024 (in French)
DurationMost companies exist for an unlimited period, until they are dissolved.
Unlimited
Statutory auditorA statutory auditor is a registered auditor who checks the annual accounts. Small companies need not have one. According to the deed, the legal criteria do not require one here.
No statutory auditor

Shareholders

Network & group

No group

APSYZ has no parent and no holdings in its annual accounts. SZEDLESKI Christelle Marie Ghislaine is the only director.

At the same address

Drève des Arches 12, 5340 Gesves · 1 other company
ENG&OP
registered office since 17-08-2018 · founded in 2018
turnover €95,266 (2025)
0700.721.169

Earlier ties

ENG&OP
via SZEDLESKI Christelle Marie Ghislaine, no longer at ENG&OP · Director (not named in the articles) · deed of 07-09-2020
founded in 2018
turnover €95,266 (2025)

Connections & network

Depth

The network starts from the earlier ties.

This company Company Director Shareholding +N: links not shown yet Click a node to look further, drag to arrange, zoom with the mouse wheel.

Timeline

Timeline

6 events since 2024

Deadline for the 2026 accounts: 31-07-2027

2026
Resignation: Fabian Leroy (director)General meeting of 02-01-20262 points ▸
  • General meeting, 02-01-2026
  • Director resignation, Fabian Leroy

Open the deed in the Belgian Official Gazette

Annual accounts 2025 filed NBBabbreviated format · 1 day before the deadline
2025
Registered in the Peppol Directory Reachable for e-invoices through 0208:1007357470
Annual accounts 2024 filed PDFfull format · 28 days late
2024
IncorporationFounding capital of €3,000, 100 shares · Founders: LEROY Fabian Michel Laurent and SZEDLESKI Christelle Marie Ghislaine · Appointments: SZEDLESKI Christelle Marie Ghislaine (director) and LEROY Fabian Michel Laurent (director) · published on 22-03-20248 points ▸

Open the deed in the Belgian Official Gazette

First establishment Drève des Arches 12, Gesves

Sources: Publications in the Belgian Official GazetteFilings with the National Bank

History

On 20 March 2024, APSYZ was incorporated as a private limited company by two natural persons, with a starting capital of €3,000.12 SZEDLESKI Christelle Marie Ghislaine is director of the company, appointed by deed of 22-03-2024.2 The company has filed 2 sets of annual accounts, the latest for financial year 2025.3

  1. 1KBO register
  2. 2Belgian Official Gazette, 22-03-2024
  3. 3National Bank, annual accounts 2025

Company details

Identity

Enterprise number
1007.357.470
VAT number
BE 1007.357.470
Peppol ID
0208:1007357470
Other Peppol ID
9925:BE1007357470
Legal form
Private limited company
Status
Active, normal situation
Founded
20-03-2024
Financial year
ends on 31 December
Peppol
Reachable since 04-12-2025Follow this company and you will hear the next morning if it leaves the Peppol register.
Name
APSYZ in French
Entity type
Legal entity
DurationMost companies exist for an unlimited period, until they are dissolved.
Unlimited
deed of 22-03-2024 (in French)

Activities

NACEBEL 2025
86931 Psychology services main activity
85409 Education
PurposeThe purpose describes the activities the company may carry out under its articles.
“Les consultations de psychologie clinique sur base individuelle ou collective; Toutes activités relatives à la santé mentale,sauf hôpitaux…”
8 activities
  1. Les consultations de psychologie clinique sur base individuelle ou collective ;
  2. Toutes activités relatives à la santé mentale,sauf hôpitaux et maisons de soins psychiatriques ;
  3. Toutes activités d’enseignement par rapport à ce qui précède.
  4. Gestion d’un patrimoine mobilier et immobilier,tant en Belgique,qu'à l'étranger,pour compte propre,ou pour compte de tiers,ou en participation avec des tiers;toutes opérations civiles d’achat,de vente,de transformation,d’aménagement,de conclusion de baux commerciaux et/ou civils,de sous-location,d’échange et de vente de tous immeubles à l’exclusion de l’entreprise d’achat d’immeubles en vue de la revente.
  5. La commercialisation,sous toutes ses formes et notamment l’achat,la vente,en gros et en détail,le courtage et la commission des produits conçus et/ou fabriqués par elle ou par toutes autres sociétés,et notamment la vente de tout objet,matériel ou matériau en rapport avec ce qui précède ; L’importation,l’exportation,les opérations de vente et d’achats internationales,toutes activités de transport de biens et de personnes,la commercialisation de tous biens d’équipements et de marchandises de toutes natures,la représentation commerciale de toutes marques,la vente en gros,demi-gros et détail,le commerce en général.
  6. Contracter ou consentir tout prêt généralement quelconque;tout ce qui est utile ou nécessaire à l’accomplissement de son objet social;tantes en Belgique qu’à l’étranger,toutes opérations commerciales,industrielles,mobilières,immobilières ou financières se rattachant directement ou indirectement à son objet social et notamment l’achat,la vente,la location de tous biens meubles,immeubles ou fonds de commerce appartenant à la société.
  7. Acquérir,aliéner,prendre ou donner en location tous immeuble ou fonds de commerce,acquérir,céder tous brevets,licences,marques de fabrique ou de commerce,s’intéresser de toutes les manières,sous toutes les formes et en tous lieux,à toutes sociétés ou entreprises,affaires,associations et institutions dont l’objet social serait similaire,analogue ou connexe au sien,ou simplement utile à l’extension de ses opérations.
  8. En recourant à l’association,au partenariat ou à la sous-traitance de toutes entreprises titulaires des accès à la profession,agréations ou enregistrements requis,toutes opérations mobilières,immobilières,commerciales,industrielles,financières et autres se rapportant directement ou indirectement à son objet social,ou susceptibles de contribuer à son développement;tous placements en valeurs mobilières,s’intéresser par voie d’association,d’apport ou de fusion,de souscription,de participation,d’intervention financière ou autrement,à ou dans toutes sociétés ou entreprises,existantes ou à créer,et conférer toutes sûretés pour compte de tiers.
deed of 22-03-2024 (in French)

Registered office and establishments

1 establishment
Establishment Since Unit number
Drève des Arches 12 registered office 5340 Gesves 20-03-2024 2.358.898.260

Buildings and parcels at the address

Ground area
1,215 m²
Buildings
122 m²
Volume, LiDAR
803 m³
Tallest building
8.4 m
Buildings to scale, each on its own parcel
122 m², 8.4 m 122 m², 8.4 m

Location

registered office establishment The establishment unit on the map
2 companies at this address See who is registered here

Parcels

Cadastral parcelArea Buildings Height / floors
92042D0194/00G0321,215 m² 1 · 122 m² 8.4 m · 2

Contact

E-mail chris.szed@gmail.com
Phone +32 478 94 01 23